We evaluated the feasibility and efficacy of a commercially available methicillin-resistant Staphylococcus aureus (MRSA)-selective agar, chromID(™) MRSA, to detect group B streptococci with reduced penicillin susceptibility (PRGBS) in this study. The results showed 72.4% (21/29) sensitivity and 98.4% (60/61) specificity to detect PRGBS using this method.
Keywords: Commercially available; Group B Streptococcus; Group B streptococci with reduced penicillin susceptibility; Methicillin-resistant Staphylococcus aureus (MRSA)-selective agar plate; PRGBS; Streptococcus agalactiae.
Copyright © 2016 Elsevier Inc. All rights reserved.